Drugs / GSK Biologicals' Pneumococcal Conjugate Vaccine
GSK Biologicals' Pneumococcal Conjugate Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00333450 | Aug → Dec 2006 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK Biologicals' Pneumococcal Conjugate Vaccine | “Multicentre Immune Memory Study in Healthy Children Following a 3 Dose Primary Vaccination With Prevenar or GSK Biologicals' Pneumococcal Conjugate Vaccine Via the...” NCT00333450 ↗ |
| Modality | Vaccine | “GSK Biologicals' Pneumococcal Conjugate Vaccine” NCT00333450 ↗ |